JP3747665B2 - Halohydrin derivative and process for producing the same - Google Patents

Halohydrin derivative and process for producing the same Download PDF

Info

Publication number
JP3747665B2
JP3747665B2 JP35027098A JP35027098A JP3747665B2 JP 3747665 B2 JP3747665 B2 JP 3747665B2 JP 35027098 A JP35027098 A JP 35027098A JP 35027098 A JP35027098 A JP 35027098A JP 3747665 B2 JP3747665 B2 JP 3747665B2
Authority
JP
Japan
Prior art keywords
general formula
derivative represented
mmol
reaction
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP35027098A
Other languages
Japanese (ja)
Other versions
JPH11236357A (en
Inventor
崇 三木
寿也 高橋
敦史 古谷
信三 世古
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP35027098A priority Critical patent/JP3747665B2/en
Publication of JPH11236357A publication Critical patent/JPH11236357A/en
Application granted granted Critical
Publication of JP3747665B2 publication Critical patent/JP3747665B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、医薬中間体、例えばレチノールの中間体として有用な下記一般式(1)または(2)で示されるハロヒドリン誘導体およびその製造法に関する。
【0002】
【従来の技術】
従来、一般式(1)または(2)で示されるハロヒドリン誘導体は知られていない。
【0003】
【発明が解決しようとする課題】
本発明は、一般式(1)または(2)で示されるハロヒドリン誘導体およびその製造法を提供しようとするものである。
【0004】
【課題を解決するための手段】
本発明者らは、上記課題を解決するために鋭意検討した結果本発明に至った。
すなわち、本発明は、一般式(1)

Figure 0003747665
(式中、Rは水素原子またはヒドロキシル基の保護基を示し、Xはハロゲン原子を示す。)
で示されるハロヒドリン誘導体、一般式(2)
Figure 0003747665
(式中、RおよびXは前記と同じ意味を表わす。)
で示されるハロヒドリン誘導体およびそれらの製造法を提供するものである。
【0005】
【発明の実施の形態】
以下本発明について、詳細に説明する。
【0006】
本発明のハロヒドリン誘導体(1)または(2)は、一般式(3)
Figure 0003747665
(式中、Rは前記と同じ意味を表わす。)
で示されるトリエン誘導体をハロヒドリン化反応に供することにより得られる。
【0007】
一般式(1)、(2)、および(3)で示される化合物において、Rは水素原子もしくはヒドロキシル基の保護基を示す。
ヒドロキシル基の保護基としては例えば、ホルミル、アセチル、ピバロイル、ベンゾイル、p−ニトロベンゾイルなどのアシル基、トリメチルシリル、t−ブチルジメチルシリル、t−ブチルジフェニルシリルなどのシリル基、テトラヒドロピラニル、メトキシメチル、メトキシエトキシメチル、1−エトキシエチルなどのアルコキシメチル基、ベンジル基、p−メトキシベンジル基、t−ブチル基、トリチル基、メチル基、2,2,2−トリクロロエトキシカルボニル基、アリルオキシカルボニル基等が挙げられる。
【0008】
一般式(1)または(2)で示される化合物において、Xのハロゲン原子としては、塩素原子、臭素原子、またはヨウ素原子が挙げられる。
【0009】
なお、原料化合物である一般式(3)で示されるトリエン誘導体はゲラニオールより容易に製造でき、EまたはZの幾何異性体のいずれであってもよく、またその混合物であってもよい。
【0010】
本発明でハロヒドリン化反応に用いられる過ハロゲン酸もしくはハロゲン酸またはそれらの金属塩としては、具体的には過ヨウ素酸ナトリウム、過ヨウ素酸カリウム、過ヨウ素酸、臭素酸、臭素酸ナトリウム、臭素酸カリウム等が挙げられる。その使用量は一般式(3)で示されるトリエン誘導体に対して、通常0.5〜5モル倍程度、好ましくは0.8〜1.2モル倍程度の範囲である。
また、還元剤としては、亜硫酸水素塩、亜硫酸塩、チオ硫酸塩もしくはそれらの水溶液が挙げられ、好ましくは、亜硫酸水素塩が挙げられる。具体的には、亜硫酸水素ナトリウム、亜硫酸ナトリウム、チオ硫酸ナトリウム等が挙げられる。その使用量は一般式(3)で示されるトリエン誘導体に対して、通常1〜10モル倍程度、好ましくは1.6〜2.4モル倍程度の範囲である。
【0011】
本発明でハロヒドリン化反応に用いられるハロゲン化剤としては、例えば塩素、次亜塩素酸、次亜塩素酸t−ブチル、次亜塩素酸エチル、次亜塩素酸ナトリウム、次亜塩素酸カリウム、次亜塩素酸カルシウム、N−クロロ尿素、N−クロロスクシンイミド、クロラミンT、クロラミンBなどの塩素化剤、臭素、次亜臭素酸、次亜臭素酸t−ブチル、次亜臭素酸ナトリウム、次亜臭素酸カリウム、N−ブロモ酢酸アミド、N−ブロモスクシンイミドなどの臭素化剤、ヨウ素、N−ヨードスクシンイミドなどのヨウ素化剤が挙げられる。その使用量は、特には限定されないが、一般式(3)で示されるトリエン誘導体に対して、約1〜2モル倍程度で充分目的を達することができる。
【0012】
本発明の反応には一般的には有機溶媒が用いられ、水との混合溶媒として用いても好ましい。有機溶媒としてはアセトニトリルなどのニトリル類、テトラヒドロフラン、ジオキサン、ジメトキシエタン、ジエチルエーテルなどのエーテル類、t−ブチルアルコール、t−アミルアルコール、2−プロパノールなどのアルコール類、塩化メチレン、クロロホルム、四塩化炭素などのハロゲン化炭化水素類、アセトン、メチルイソプロピルケトン、メチルイソブチルケトンなどのケトン類、ジメチルスルホキシド、アセトニトリル、N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミドなどの非プロトン性極性溶媒が挙げられる。また使用量は特に限定されない。
【0013】
本発明の反応温度は通常−78℃〜溶媒の沸点の範囲、好ましくは0〜40℃の範囲である。また、反応時間は反応温度によって異なるが、通常10分〜48時間の範囲である。
【0014】
反応終了後、得られた反応混合物に水を加え、抽出した後、水等で洗浄し、有機層を濃縮することにより一般式(1)および(2)で示されるハロヒドリン誘導体を得ることができる。また、必要に応じて、シリカゲルクロマトグラフィーにより精製することができる。
【0015】
【発明の効果】
本発明により得られる一般式(1)、(2)で示されるハロヒドリン誘導体は、医薬等中間体、例えばレチノールの中間体として有用である。
【0016】
【実施例】
以下、実施例により本発明をさらに詳細に説明するが、本発明はこれにより限定されるものではない。
【0017】
(実施例1)
酢酸 3,7−ジメチル−2,5,7−オクタトリエニル(5.16g、26.6mmol)およびイオン交換水(0.48g、26.6mmol)を含むジメチルスルホキシド(40mL)の混合溶液を10℃に冷却し、これにN−ブロモスクシンイミド(4.78g、26.6mmol)を加えた。反応容器を冷媒から取り出し、室温で40分攪拌した。ガスクロマトグラフィーで原料の消失を確認したのち、イオン交換水(40mL)を加えた。これに酢酸エチル(40mL)を加えて分液したのち、さらに水層を酢酸エチル(35mLx2)で抽出した。合わせた有機層を5%炭酸水素ナトリウム水(20mL)、飽和塩化ナトリウム水(20mL)で順次洗浄し、無水硫酸ナトリウムにて乾燥した。減圧濃縮して得られた黄色油状物(9.12g)をシリカゲルカラムクロマトグラフィー(展開溶媒ヘキサン:酢酸エチル=5:1、ついで3:1)に供し、酢酸 8−ブロモ−7−ヒドロキシ−3,7−ジメチル−2,5−オクタジエニル(1,2付加体)(4.84g、収率62.5%)および酢酸 8−ブロモ−5−ヒドロキシ−3,7−ジメチル−2,6−オクタジエニル(1,4付加体)(1.28g、収率16.5%)を得た。
[1,2付加体]
Rf:0.30(吸着剤 シリカゲル、展開溶媒 ヘキサン:酢酸エチル=3:1)
1H NMR(270MHz,CDCl3):δ 1.43(s,3H),1.70(s,3H),2.06(s,3H),2.34(s,1H),2.78(d,J=6.9Hz,2H),3.47(s,2H),4.59(d,J=6.6Hz,2H),5.38(t,J=6.6Hz,1H),5.57(d,J=15.5Hz,1H),5.74(dt,J=15.5Hz,6.9Hz,1H)
13C NMR(67.8MHz,CDCl3):δ 16.43,20.94,26.15,41.98,45.00,61.17,71.27,119.43,127.67,135.38,140.29,170.98
[1,4付加体]
Rf:0.14(吸着剤 シリカゲル、展開溶媒 ヘキサン:酢酸エチル=3:1)
1H NMR(270MHz,CDCl3):δ 1.76(s,3H),1.82(s,3H),2.06(s,3H),2.20(dd,J=13.5Hz,5.6Hz,1H),2.30(dd,J=13.5Hz,7.9Hz,1H),2.67(br,1H),3.95(s,2H),4.49(ddd,J=8.6Hz,7.9Hz,5.6Hz,1H),4.59(d,J=6.9Hz,2H),5.42(t,J=6.9Hz,1H),5.58(d,J=8.6Hz,1H)
13C NMR(67.8MHz,CDCl3):δ 14.94,16.62,20.76,40.07,46.81,60.90,66.09,121.92,132.65,133.72,137.48,170.89
【0018】
(実施例2)
酢酸 3,7−ジメチル−2,5,7−オクタトリエニル(500mg、2.57mmol)を水10mlとアセトニトリル5mlに溶解させ、過ヨウ素酸ソーダ(550mg、2.58mmol)を室温で添加して、その後1MのNaHSO3水溶液5.4mlを室温で1時間かけて滴下した。室温で5時間攪拌して、TLCにて原料が消失したのを確認して、水を注加してエーテルにて抽出した。有機層はNa2SO3水溶液にて洗浄して無水硫酸マグネシウムにて乾燥し、溶媒を留去することにより酢酸 8−ヨード−7−ヒドロキシ−3,7−ジメチル−2,6−オクタジエニル(870mg、2.57mmol)を100%の収率で得た。
【0019】
(実施例3)
酢酸 3,7−ジメチル−2,5,7−オクタトリエニル(500mg、2.57mmol)を水6mlとアセトニトリル10mlに溶解させ、過ヨウ素酸2水和物(710mg、3.09mmol)を室温で添加して、その後1MのNaHSO3水溶液5.4mlを0℃で1時間かけて滴下した。室温で2時間攪拌して、TLCにて原料が消失したのを確認して、水を注加してエーテルにて抽出した。有機層はNa2SO3水溶液にて洗浄して無水硫酸マグネシウムにて乾燥し、溶媒を留去することにより酢酸 8−ヨード−7−ヒドロキシ−3,7−ジメチル−2,5−オクタジエニルと酢酸 8−ヨード−5−ヒドロキシ−3,7−ジメチル−2,5−オクタジエニルの約3:2の混合物(800mg、2.36mmol)を92%の収率で得た。
【0020】
(実施例4)
酢酸 3,7−ジメチル−2,5,7−オクタトリエニル(1.0g、5.15mmol)を水20mlとアセトニトリル10mlに溶解させ、臭素酸ソーダ(0.93g、6.18mmol)を室温で添加して、その後1MのNaHSO3水溶液12.4mlを室温で1時間かけて滴下した。室温で5時間攪拌して、TLCにて原料が消失したのを確認して、水を注加してエーテルにて抽出した。有機層はNa2SO3水溶液にて洗浄して無水硫酸マグネシウムにて乾燥し、溶媒を留去することにより酢酸 8−ブロモ−7−ヒドロキシ−3,7−ジメチル−2,5−オクタジエニルと酢酸 8−ブロモ−5−ヒドロキシ−3,7−ジメチル−2,6−オクタジエニルの約7:3の混合物(1.4g、4.89mmol)を95%の収率で得た。これらはカラムクロマトグラフィーによって分離できた。
【0021】
(実施例5)
酢酸 3,7−ジメチル−2,5,7−オクタトリエニル(387mg、1.99mmol)をアセトニトリル5mlに溶解させ、臭素(400mg、2.50mmol)を水5mlとアセトニトリル1mlに溶解させた溶液を室温で滴下した。室温で8時間攪拌して、TLCにて原料が消失したのを確認して、水を注加してエーテルにて抽出した。有機層は食塩水にて洗浄して無水硫酸マグネシウムにて乾燥し、溶媒を留去することにより酢酸 8−ブロモ−7−ヒドロキシ−3,7−ジメチル−2,5−オクタジエニルと酢酸 8−ブロモ−5−ヒドロキシ−3,7−ジメチル−2,6−オクタジエニルの約7:3の混合物(569mg、1.95mmol)を98%の収率で得た。これらはカラムクロマトグラフィーによって分離できた。
【0022】
(参考例1)
酢酸ゲラニル(40g、20.4mmol)をヘキサン(100mL)に溶解し、トリクロロイソシアヌル酸(17.1g、70.0mmol)を徐々に仕込み、−10℃〜0℃で6時間保温する。反応終了後、過剰のトリクロロイソシアヌル酸および副生するイソシアヌル酸をろ過により系外に除去した。ろ液を5%炭酸水素ナトリウム、イオン交換水で順次洗浄し、無水硫酸ナトリウムで乾燥したのち、溶媒を留去することにより粗生成物を得た。これをシリカゲルカラムクロマトグラフィーに供し、目的の酢酸 6−クロロ−3,7−ジメチル−2,7−オクタジエニルを淡黄色油状物として、収率85.5%で得た。
【0023】
(参考例2)
乾燥した4口フラスコに窒素下、微粉末の水酸化ナトリウム(6.8g、0.17mol)、トリフェニルホスフィン(2.2g、8.5mmol)、塩化テトラn−ブチルアンモニウム(1.4g、5.1mmol)、塩化アリルパラジウムダイマー(0.62g、1.7mmol)、テトラヒドロフラン(100mL)を加える。そこへ、攪拌下、酢酸 6−クロロ−3,7−ジメチル−2,7−オクタジエニル(40g、0.17mmol)のテトラヒドロフラン溶液(150mL)を室温で1時間かけて滴下する。室温で3日間攪拌後、TLCにて原料の消失を確認して、反応を終了する。反応混合物を水にあけ、エーテルで抽出する。有機層を飽和塩化ナトリウム水溶液で洗浄し、無水硫酸ナトリウムで乾燥し、溶媒を留去して粗生成物を得た。これをシリカゲルカラムクロマトグラフィーに供し、酢酸 3,7−ジメチル−2,5,7−オクタトリエニルを淡黄色油状物として収率65%で得た。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a halohydrin derivative represented by the following general formula (1) or (2) useful as a pharmaceutical intermediate, for example, an intermediate of retinol, and a method for producing the same.
[0002]
[Prior art]
Conventionally, a halohydrin derivative represented by the general formula (1) or (2) has not been known.
[0003]
[Problems to be solved by the invention]
The present invention intends to provide a halohydrin derivative represented by the general formula (1) or (2) and a method for producing the same.
[0004]
[Means for Solving the Problems]
The inventors of the present invention have made the present invention as a result of intensive studies to solve the above problems.
That is, the present invention relates to the general formula (1)
Figure 0003747665
(In the formula, R represents a hydrogen atom or a hydroxyl-protecting group, and X represents a halogen atom.)
A halohydrin derivative represented by the general formula (2)
Figure 0003747665
(In the formula, R and X have the same meaning as described above.)
The halohydrin derivative shown by these and its manufacturing method are provided.
[0005]
DETAILED DESCRIPTION OF THE INVENTION
The present invention will be described in detail below.
[0006]
The halohydrin derivative (1) or (2) of the present invention has the general formula (3)
Figure 0003747665
(Wherein R represents the same meaning as described above.)
It is obtained by subjecting the triene derivative represented by the formula to halohydrination reaction.
[0007]
In the compounds represented by the general formulas (1), (2), and (3), R represents a hydrogen atom or a hydroxyl-protecting group.
Examples of hydroxyl protecting groups include acyl groups such as formyl, acetyl, pivaloyl, benzoyl, and p-nitrobenzoyl, silyl groups such as trimethylsilyl, t-butyldimethylsilyl, and t-butyldiphenylsilyl, tetrahydropyranyl, and methoxymethyl. , Alkoxymethyl groups such as methoxyethoxymethyl and 1-ethoxyethyl, benzyl group, p-methoxybenzyl group, t-butyl group, trityl group, methyl group, 2,2,2-trichloroethoxycarbonyl group, allyloxycarbonyl group Etc.
[0008]
In the compound represented by the general formula (1) or (2), examples of the halogen atom for X include a chlorine atom, a bromine atom, and an iodine atom.
[0009]
The triene derivative represented by the general formula (3), which is a raw material compound, can be easily produced from geraniol, and may be either E or Z geometric isomers or a mixture thereof.
[0010]
Specific examples of perhalogen acids or halogen acids or metal salts thereof used in the halohydrination reaction in the present invention include sodium periodate, potassium periodate, periodic acid, bromic acid, sodium bromate, and bromic acid. Potassium etc. are mentioned. The amount used is usually in the range of about 0.5 to 5 moles, preferably about 0.8 to 1.2 moles, relative to the triene derivative represented by the general formula (3).
Moreover, as a reducing agent, bisulfite, sulfite, thiosulfate, or those aqueous solution is mentioned, Preferably, bisulfite is mentioned. Specific examples include sodium bisulfite, sodium sulfite, and sodium thiosulfate. The amount used is usually in the range of about 1 to 10 mol times, preferably about 1.6 to 2.4 mol times with respect to the triene derivative represented by the general formula (3).
[0011]
Examples of the halogenating agent used in the halohydrination reaction in the present invention include chlorine, hypochlorous acid, t-butyl hypochlorite, ethyl hypochlorite, sodium hypochlorite, potassium hypochlorite, Chlorinating agents such as calcium chlorite, N-chlorourea, N-chlorosuccinimide, chloramine T, chloramine B, bromine, hypobromite, t-butyl hypobromite, sodium hypobromite, hypobromite Examples include brominating agents such as potassium acid, N-bromoacetamide, and N-bromosuccinimide, and iodinating agents such as iodine and N-iodosuccinimide. The amount used is not particularly limited, but the objective can be sufficiently achieved by about 1 to 2 mole times the triene derivative represented by the general formula (3).
[0012]
In the reaction of the present invention, an organic solvent is generally used, and it is preferable to use it as a mixed solvent with water. Organic solvents include nitriles such as acetonitrile, ethers such as tetrahydrofuran, dioxane, dimethoxyethane and diethyl ether, alcohols such as t-butyl alcohol, t-amyl alcohol and 2-propanol, methylene chloride, chloroform and carbon tetrachloride. Halogenated hydrocarbons such as, ketones such as acetone, methyl isopropyl ketone, methyl isobutyl ketone, aprotic polar solvents such as dimethyl sulfoxide, acetonitrile, N, N-dimethylformamide, N, N-dimethylacetamide, etc. . Moreover, the usage-amount is not specifically limited.
[0013]
The reaction temperature of the present invention is usually in the range of −78 ° C. to the boiling point of the solvent, preferably in the range of 0 to 40 ° C. Moreover, although reaction time changes with reaction temperature, it is the range of 10 minutes-48 hours normally.
[0014]
After completion of the reaction, water is added to the resulting reaction mixture, followed by extraction, washing with water, etc., and concentrating the organic layer to obtain halohydrin derivatives represented by the general formulas (1) and (2). . If necessary, it can be purified by silica gel chromatography.
[0015]
【The invention's effect】
The halohydrin derivatives represented by the general formulas (1) and (2) obtained by the present invention are useful as intermediates for pharmaceuticals such as retinol.
[0016]
【Example】
EXAMPLES Hereinafter, although an Example demonstrates this invention further in detail, this invention is not limited by this.
[0017]
Example 1
A mixed solution of dimethyl sulfoxide (40 mL) containing 3,7-dimethyl-2,5,7-octatrienyl acetate (5.16 g, 26.6 mmol) and ion-exchanged water (0.48 g, 26.6 mmol) was added. Cooled to ° C., N-bromosuccinimide (4.78 g, 26.6 mmol) was added thereto. The reaction vessel was removed from the refrigerant and stirred at room temperature for 40 minutes. After confirming disappearance of the raw material by gas chromatography, ion-exchanged water (40 mL) was added. Ethyl acetate (40 mL) was added thereto for liquid separation, and the aqueous layer was further extracted with ethyl acetate (35 mL × 2). The combined organic layers were washed successively with 5% aqueous sodium hydrogen carbonate (20 mL) and saturated aqueous sodium chloride (20 mL), and dried over anhydrous sodium sulfate. The yellow oil (9.12 g) obtained by concentration under reduced pressure was subjected to silica gel column chromatography (developing solvent hexane: ethyl acetate = 5: 1, then 3: 1), and acetic acid 8-bromo-7-hydroxy-3. , 7-dimethyl-2,5-octadienyl (1,2 adduct) (4.84 g, 62.5% yield) and acetic acid 8-bromo-5-hydroxy-3,7-dimethyl-2,6-octadienyl (1,4 adduct) (1.28 g, yield 16.5%) was obtained.
[1,2 adduct]
Rf: 0.30 (adsorbent silica gel, developing solvent hexane: ethyl acetate = 3: 1)
1 H NMR (270 MHz, CDCl 3 ): δ 1.43 (s, 3H), 1.70 (s, 3H), 2.06 (s, 3H), 2.34 (s, 1H), 2.78 (D, J = 6.9 Hz, 2H), 3.47 (s, 2H), 4.59 (d, J = 6.6 Hz, 2H), 5.38 (t, J = 6.6 Hz, 1H) , 5.57 (d, J = 15.5 Hz, 1H), 5.74 (dt, J = 15.5 Hz, 6.9 Hz, 1H)
13 C NMR (67.8 MHz, CDCl 3 ): δ 16.43, 20.94, 26.15, 41.98, 45.00, 61.17, 71.27, 119.43, 127.67, 135 .38, 140.29, 170.98
[1,4-adduct]
Rf: 0.14 (adsorbent silica gel, developing solvent hexane: ethyl acetate = 3: 1)
1 H NMR (270 MHz, CDCl 3 ): δ 1.76 (s, 3H), 1.82 (s, 3H), 2.06 (s, 3H), 2.20 (dd, J = 13.5 Hz, 5.6 Hz, 1H), 2.30 (dd, J = 13.5 Hz, 7.9 Hz, 1H), 2.67 (br, 1H), 3.95 (s, 2H), 4.49 (ddd, J = 8.6 Hz, 7.9 Hz, 5.6 Hz, 1H), 4.59 (d, J = 6.9 Hz, 2H), 5.42 (t, J = 6.9 Hz, 1H), 5.58 (D, J = 8.6Hz, 1H)
13 C NMR (67.8 MHz, CDCl 3 ): δ 14.94, 16.62, 20.76, 40.07, 46.81, 60.90, 66.09, 121.92, 132.65, 133 72, 137.48, 170.89
[0018]
(Example 2)
3,7-dimethyl-2,5,7-octatrienyl acetate (500 mg, 2.57 mmol) was dissolved in 10 ml of water and 5 ml of acetonitrile, and sodium periodate (550 mg, 2.58 mmol) was added at room temperature. Then, 5.4 ml of 1M NaHSO 3 aqueous solution was added dropwise at room temperature over 1 hour. The mixture was stirred at room temperature for 5 hours. After confirming disappearance of the raw material by TLC, water was added and extracted with ether. The organic layer was washed with an aqueous Na 2 SO 3 solution and dried over anhydrous magnesium sulfate, and the solvent was distilled off to remove acetic acid 8-iodo-7-hydroxy-3,7-dimethyl-2,6-octadienyl (870 mg). 2.57 mmol) in 100% yield.
[0019]
Example 3
3,7-dimethyl-2,5,7-octatrienyl acetate (500 mg, 2.57 mmol) was dissolved in 6 ml of water and 10 ml of acetonitrile, and periodic acid dihydrate (710 mg, 3.09 mmol) was dissolved at room temperature. Then, 5.4 ml of 1M NaHSO 3 aqueous solution was added dropwise at 0 ° C. over 1 hour. The mixture was stirred at room temperature for 2 hours. After confirming disappearance of the raw material by TLC, water was added and extracted with ether. The organic layer is washed with an aqueous Na 2 SO 3 solution and dried over anhydrous magnesium sulfate, and the solvent is distilled off to remove acetic acid 8-iodo-7-hydroxy-3,7-dimethyl-2,5-octadienyl and acetic acid. An approximately 3: 2 mixture (800 mg, 2.36 mmol) of 8-iodo-5-hydroxy-3,7-dimethyl-2,5-octadienyl was obtained in 92% yield.
[0020]
(Example 4)
3,7-dimethyl-2,5,7-octatrienyl acetate (1.0 g, 5.15 mmol) was dissolved in 20 ml of water and 10 ml of acetonitrile, and sodium bromate (0.93 g, 6.18 mmol) was dissolved at room temperature. After that, 12.4 ml of 1M aqueous NaHSO 3 solution was added dropwise at room temperature over 1 hour. The mixture was stirred at room temperature for 5 hours. After confirming disappearance of the raw material by TLC, water was added and extracted with ether. The organic layer was washed with an aqueous Na2SO3 solution and dried over anhydrous magnesium sulfate, and the solvent was distilled off to remove acetic acid 8-bromo-7-hydroxy-3,7-dimethyl-2,5-octadienyl and acetic acid 8-bromo. An approximately 7: 3 mixture (1.4 g, 4.89 mmol) of -5-hydroxy-3,7-dimethyl-2,6-octadienyl was obtained in 95% yield. These could be separated by column chromatography.
[0021]
(Example 5)
A solution prepared by dissolving 3,7-dimethyl-2,5,7-octatrienyl acetate (387 mg, 1.99 mmol) in 5 ml of acetonitrile and bromine (400 mg, 2.50 mmol) in 5 ml of water and 1 ml of acetonitrile was used. Added dropwise at room temperature. The mixture was stirred at room temperature for 8 hours. After confirming disappearance of the raw material by TLC, water was added and the mixture was extracted with ether. The organic layer was washed with brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off to remove acetic acid 8-bromo-7-hydroxy-3,7-dimethyl-2,5-octadienyl and acetic acid 8-bromo. An approximately 7: 3 mixture (569 mg, 1.95 mmol) of -5-hydroxy-3,7-dimethyl-2,6-octadienyl was obtained in 98% yield. These could be separated by column chromatography.
[0022]
(Reference Example 1)
Geranyl acetate (40 g, 20.4 mmol) is dissolved in hexane (100 mL), trichloroisocyanuric acid (17.1 g, 70.0 mmol) is gradually added, and the mixture is kept at -10 ° C to 0 ° C for 6 hours. After completion of the reaction, excess trichloroisocyanuric acid and by-product isocyanuric acid were removed from the system by filtration. The filtrate was washed successively with 5% sodium hydrogen carbonate and ion-exchanged water, dried over anhydrous sodium sulfate, and the solvent was distilled off to obtain a crude product. This was subjected to silica gel column chromatography, and the target 6-chloro-3,7-dimethyl-2,7-octadienyl acetate was obtained as a pale yellow oil in a yield of 85.5%.
[0023]
(Reference Example 2)
In a dry 4-necked flask under nitrogen, fine powdered sodium hydroxide (6.8 g, 0.17 mol), triphenylphosphine (2.2 g, 8.5 mmol), tetra n-butylammonium chloride (1.4 g, 5 0.1 mmol), allyl palladium chloride dimer (0.62 g, 1.7 mmol), tetrahydrofuran (100 mL). Thereto, a tetrahydrofuran solution (150 mL) of 6-chloro-3,7-dimethyl-2,7-octadienyl acetate (40 g, 0.17 mmol) is added dropwise at room temperature over 1 hour with stirring. After stirring at room temperature for 3 days, the disappearance of the raw material is confirmed by TLC, and the reaction is completed. The reaction mixture is poured into water and extracted with ether. The organic layer was washed with a saturated aqueous sodium chloride solution and dried over anhydrous sodium sulfate, and the solvent was distilled off to obtain a crude product. This was subjected to silica gel column chromatography to obtain 3,7-dimethyl-2,5,7-octatrienyl acetate as a pale yellow oil in a yield of 65%.

Claims (6)

一般式(1)
Figure 0003747665
(式中、Rは水素原子またはヒドロキシル基の保護基を示し、Xはハロゲン原子を示す。)で示されるハロヒドリン誘導体または
一般式(2)
Figure 0003747665
(式中、RおよびXは前記と同じ意味を表わす。)
で示されるハロヒドリン誘導体。
General formula (1)
Figure 0003747665
(Wherein R represents a hydrogen atom or a protecting group for a hydroxyl group, and X represents a halogen atom) or a halohydrin derivative represented by the general formula (2)
Figure 0003747665
(In the formula, R and X have the same meaning as described above.)
A halohydrin derivative represented by
一般式(3)
Figure 0003747665
(式中、Rは前記と同じ意味を表わす。)
で示されるトリエン誘導体をハロヒドリン化反応させることを特徴とする一般式(1)で示されるハロヒドリン誘導体および一般式(2)で示されるハロヒドリン誘導体の製造法。
General formula (3)
Figure 0003747665
(Wherein R represents the same meaning as described above.)
A method for producing a halohydrin derivative represented by the general formula (1) and a halohydrin derivative represented by the general formula (2), wherein the triene derivative represented by the formula (1) is subjected to a halohydrination reaction.
ハロヒドリン化反応に過ハロゲン酸もしくはハロゲン酸またはそれらの金属塩ならびに還元剤を用いる請求項2に記載の製造法。The process according to claim 2, wherein a perhalogen acid or a halogen acid or a metal salt thereof and a reducing agent are used in the halohydrination reaction. ハロヒドリン化反応にハロゲン化剤と水とを用いる請求項2に記載の製造法。The production method according to claim 2, wherein a halogenating agent and water are used in the halohydrination reaction. 還元剤が亜硫酸水素塩、亜硫酸塩、チオ硫酸塩またはそれらの水溶液である請求項3に記載の製造法。The process according to claim 3, wherein the reducing agent is bisulfite, sulfite, thiosulfate or an aqueous solution thereof. 反応温度が0℃〜40℃である請求項2に記載の製造法。The process according to claim 2, wherein the reaction temperature is from 0C to 40C.
JP35027098A 1997-12-11 1998-12-09 Halohydrin derivative and process for producing the same Expired - Fee Related JP3747665B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP35027098A JP3747665B2 (en) 1997-12-11 1998-12-09 Halohydrin derivative and process for producing the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34127197 1997-12-11
JP9-341271 1997-12-11
JP35027098A JP3747665B2 (en) 1997-12-11 1998-12-09 Halohydrin derivative and process for producing the same

Publications (2)

Publication Number Publication Date
JPH11236357A JPH11236357A (en) 1999-08-31
JP3747665B2 true JP3747665B2 (en) 2006-02-22

Family

ID=26576931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP35027098A Expired - Fee Related JP3747665B2 (en) 1997-12-11 1998-12-09 Halohydrin derivative and process for producing the same

Country Status (1)

Country Link
JP (1) JP3747665B2 (en)

Also Published As

Publication number Publication date
JPH11236357A (en) 1999-08-31

Similar Documents

Publication Publication Date Title
JP7330537B2 (en) Preparation of 3-hydroxy-3,6-dimethylhexahydrobenzofuran-2-one and its derivatives
JP2505669B2 (en) Novel compound used for production of cholecalciferol derivative and process for producing the same
JP3747665B2 (en) Halohydrin derivative and process for producing the same
JP2823616B2 (en) "4,4,5,8-Tetramethyl-1-oxaspiro [2.5] octane, a method for preparing the same, and 2,2,3,6-tetramethyl-cyclohexane-carbaldehyde, a method for preparing the same"
JP3751045B2 (en) Method for producing Wittig ester salt
JP2000086645A (en) Epoxy derivative and its production
JPH0463056B2 (en)
US6348622B1 (en) Vitamin a related compounds and process for producing the same
JP2003146957A (en) Method for producing valiolamine and intermediate thereof
JP3777818B2 (en) Halogen compounds, triene derivatives and methods for producing them
JPS6140669B2 (en)
JP2000212104A (en) Production of bis (trifluoromethyl)monobromobenzene
JP4174104B2 (en) Method for producing acetylamine compound
JP2002316972A (en) Method for producing optically active 3-cyano-2- methylpropanol derivative
JP2002308864A (en) Production method for 5-propargylfurfuryl alcohol
JPS60158147A (en) Preparation of 3-amino-4-fluoro-(6-halogeno)phenyl alkyl ether
JP2642680B2 (en) Reduction of β-ketoester
JPS6126555B2 (en)
JP2000063306A (en) Trifluoropropanetetrol, its intermediate and their production
JP2003064023A (en) Method of producing optically active hydroxybutyric acid derivative
KR20040102068A (en) Method for the production of 2,4,5-trimethylphenyl acetic acid
JPS5946946B2 (en) Method for producing cyclopentanone derivative compounds
JPH11222478A (en) Production of sulfone derivative
JPH06100526A (en) Phenoxyalkylcarboxylid acid derivative
JPH07133271A (en) Banzaldehyde derivative and production of chromancarboxylic acid derivative using the same as intermediate

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20051108

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20051101

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20051121

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081209

Year of fee payment: 3

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D05

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081209

Year of fee payment: 3

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091209

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees